Failure to consider drug-drug interactions as a likely cause of behavioral deterioration in a patient with bipolar disorder.
Shad
U
U
Preskorn
S H
SH
Izgur
Z
Z
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001519:Behavior / Q000187:drug effects*; D001569:Benzodiazepines; D001590:Benztropine / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000523:psychology*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D001569:Benzodiazepines; D001590:Benztropine; D010890:Pirenzepine; D018967:Risperidone; D000077152:Olanzapine